Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma
Year: 2021
Type: article
Abstract: [Image: see text]
Source: Cancer Medicine
DOI: 10.1002/cam4.4254
Institution: Levine Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,025
OpenAlex ID: W3196901299
